Ticker

NEW YORK, March 12, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced approval of the terms of the issuance of transferable rights ("Rights") to the holders of the Fund's common stock (par value $0.0001 per share) ("Common Stock"), as of the record date, March 23, 2026 (the "Record Date"). Holders of these Rights will be entitled to subscribe for…

NEW YORK, March 12, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced an early declaration of the Fund's regular monthly distribution payable in April. The $0.0905 per share of common stock distribution announced today is payable on April 30, 2026, has a record date of April 7, 2026, and has an ex-date of April 7, 2026.

NEW YORK, Feb. 27, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on March 31, 2026, has a record date of March 16, 2026, and has an ex-date of March 16, 2026.

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS - Get Free Report)'s stock price crossed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $7.43 and traded as high as $7.65. Neuberger Berman High Yield Strategies Fund shares last traded at $7.64, with a volume

The Primary Endpoint of Statistically Significant Combined Stage III-IV Reduction Was Not Met, However A Favorable Trend Was Observed Over Time GRAIL Announces U.S. Sales Force Expansion Based on Strong NHS-Galleri and PATHFINDER 2 Trial Results MENLO PARK, Calif. and LONDON, Feb. 19, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured,…